Skip to main content

Advertisement

SpringerLink
Log in

Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Roux-en-Y gastric bypass (RYGB) is an effective treatment for morbid obesity. This bariatric procedure has also been noted to resolve hyperglycaemia in up to 70% of obese diabetics. We evaluated outcomes in diabetic patients undergoing RYGB in our institution, aiming to identify factors predicting diabetes remission.

Methods

One hundred ten type 2 diabetic (T2DM) patients undergoing RYGB were studied. Baseline demographics, diabetic status pre- and post-surgery and outcomes were evaluated. Outcomes were compared to a matched non-diabetic cohort.

Results

The mean age of the patients was 45 ± 11. The majority (70%; n = 77) were female and the mean baseline body mass index was 47 ± 7. Mean (±SD range) excess weight loss at 6, 12 and 24 months was 58.3 ± 26.4% (30.5−167%), 63.2 ± 17.2% (0−99.2%) and 84.1 ± 21.3% (16.5−121%), respectively. Diabetic medication was discontinued in 68.4% patients and reduced in a further 14.3%. Mean preoperative HbA1c was 7.1 ± 2.0 and mean postoperative HbA1c 5.48 ± 0.2. Patients with a baseline HbA1c >10 had a 50% rate of remission compared to 77.3% with an HbA1c of 6.5−7.9. The mean duration of T2DM preoperatively was 5.5 ± 7 years. A preoperative duration of T2DM greater than 10 years was shown to significantly reduce the chances of remission (p = 0.005).

Conclusions

RYGB for morbid obesity achieves significant weight reduction in diabetic patients with remission of pre-surgical hyperglycaemia in the majority. The study supports findings that a shorter duration and better control of diabetes prior to surgery corresponds to a higher rate of remission. It supports the argument for early surgical intervention in the morbidly obese diabetic patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Diabetes UK. www.diabetes.org.uk

  2. National Institute for Health. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.

    Article  Google Scholar 

  3. Wild S.H, Byrne C.D. The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. The Metabolic Syndrome. 2005:1–43

  4. National Service Framework for Diabetes: Standards, 2002

  5. Coronary Heart Disease statistics, Diabetes supplement, British Heart Foundation Statistics Database 2001

  6. Williams R, Gillam S, Murphy M. The true costs of Type 2 diabetes in the UK. Findings from T2ARDIS and CODE-2 UK. GlaxoSmithKline Uxbridge, UK; 2002

  7. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.

    Article  CAS  PubMed  Google Scholar 

  8. Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.

    Article  PubMed  Google Scholar 

  9. Whitson B, Leslie D, Kellogg T et al. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary. Study J Surg Res. 141;1:31−39

  10. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-anlysis. JAMA. 2004;292:1724–37.

    Article  CAS  PubMed  Google Scholar 

  11. Torquati A, Lufti R, Abumrad N, et al. Is Roux en Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9(8):1112–6.

    Article  PubMed  Google Scholar 

  12. Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes. A randomised controlled trial. Diabetes Care. 2009;32:580–4.

    Article  PubMed  Google Scholar 

  13. NICE 2002/041. www.nice.org.uk/guidance

  14. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? ADA consensus statement. Diabetes Care. 2009;32(11):2133–5.

    Article  PubMed  Google Scholar 

  15. Inzucchi SE. Oral antihyperglycaemic therapy for type 2 diabetes. JAMA. 2002;287:360–72.

    Article  CAS  PubMed  Google Scholar 

  16. Turner RC, Cull CA, Frighi V, et al. Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. JAMA. 1999;281:2005–12.

    Article  CAS  PubMed  Google Scholar 

  17. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diab Care. 2008;31:173–5.

    Article  Google Scholar 

  18. Sjostrom C, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes Res. 1999;7:477–84.

    CAS  PubMed  Google Scholar 

  19. Sjostrom L, Narbro K, Sjostrom D, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;23(357):741–52.

    Article  Google Scholar 

  20. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    Article  CAS  PubMed  Google Scholar 

  21. Finkelstein EA, Brown DS. A cost benefit simulation model of coverage for bariatric surgery among full time employees. Am J Manag Care. 2005;11(10):641–6.

    PubMed  Google Scholar 

  22. Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.

    PubMed  Google Scholar 

  23. Ikramuddin S, Klingman D, Swan T, et al. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetic patients. Am J Manag Care. 2009;15(9):607–15.

    PubMed  Google Scholar 

  24. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518–25.

    Article  CAS  PubMed  Google Scholar 

  25. Rubino F, Moo TA, Rosen DJ, et al. Diabetes surgery: a new approach to an old disease. Diab Care. 2009;32(2):S368–72.

    Article  Google Scholar 

  26. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic roux-en y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–85.

    PubMed  Google Scholar 

  27. Wittgrove A, Grove G. Laparoscopic gastric bypass, Roux en Y 500 patients: techniques and results, with 3-60 month follow up. Obes Surg. 2000;10:233–9.

    Article  CAS  PubMed  Google Scholar 

  28. Parikh M, Ayoung-Chee P, Romanos E, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg. 2007;205(5):631–5.

    Article  PubMed  Google Scholar 

  29. Dolan K, Bryant R, Fielding GA. Treating diabetes in the morbidly obese by laparoscopic gastric banding. Obes Surg. 2003;13(3):439–43.

    Article  PubMed  Google Scholar 

  30. Chikunguwo S, Dodson PW, Meador JG et al. Durable Resolution of Diabetes after Roux en-Y Gastric Bypass is Associated with Maintenance of Weight Loss. Abstracts: 2009 Plenary Session/ SOARD 5 (2009) S1-S23. PL-101

  31. Shah SS, Todkar JS, Shah PS. Should Gastric Bypass Operation be Done for Type 2 Diabetes in Subjects with Body Mass Index 20-34 kgs/m2? An initial Indian experience. Abstracts: 2009 Plenary Session/ SOARD 5 (2009) S1-S23. PL-107

  32. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.

    Article  PubMed  Google Scholar 

  33. Deurenberg P, Deaurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes. 1998;22:1164–71.

    Article  CAS  Google Scholar 

  34. Jia WP, Lu JX, Xiang KS, et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev. 2002;3:157–65.

    Article  CAS  PubMed  Google Scholar 

  35. Lee WJ, Wang W. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest disclosure

The authors declare that they have no conflict of interest. Results were presented at the EAES congress 2009 (oral) and IFSO 2009 (poster).

Author information

Authors and Affiliations

  1. Department of Minimally Invasive and Upper Gastrointestinal Surgery, Castle Hill Hospital, Cottingham, Yorkshire, UK

    Tom C. Hall, Mike G. C. Pellen, Peter C. Sedman & Prashant K. Jain

Authors
  1. Tom C. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mike G. C. Pellen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter C. Sedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prashant K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tom C. Hall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, T.C., Pellen, M.G.C., Sedman, P.C. et al. Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity. OBES SURG 20, 1245–1250 (2010). https://doi.org/10.1007/s11695-010-0198-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-010-0198-8

Keywords

Search

Navigation